Maharashtra to get anti COVID-19 drug Remdesivir drug from Bangladesh

Maharashtra to get anti COVID-19 drug Remdesivir drug from Bangladesh
x
Maharashtra to get anti COVID-19 drug Remdesivir drug from Bangladesh
Highlights

Maharashtra will begin trials for remdesivir, a drug that has been touted as a success in the battle against COVID-19

Mumbai: Maharashtra will begin trials for remdesivir, a drug that has been touted as a success in the battle against COVID-19. The state's COVID-19 task force that comprises doctors who look into clinical management and reports to Chief Minister Uddhav Thackeray had suggested its use to save lives.

They have asked the Chief Minister to find a way out of the bureaucratic hurdles to make the drug more accessible, sources said. Indian firms that have acquired patent licence from US pharmaceutical company Gilead Sciences are still not manufacturing and marketing the drug in the country as they don't have clearances yet, according to News 18 report. The drug will be provided to 18 medical colleges and the government is acquiring it from a Bangladeshi firm since the Indian companies are not making it.

The Maharashtra government is initially getting 3,000 vials and plans have been finalised to acquire 10,000 more vials, while it pushes the centre for clearances for the drug.

Maharashtra Minister Jitendra Ahwad has asked the centre for clearances for the drug. "From the beginning I consistently urged to DCGI and Central Health Ministry to give permission for Remedesivir Drug Y r u still holding on to permissions People are dying and this is as of now the best drug Plz save lives @drharshvardhan ji @drvgsomani ji," Mr Ahwad tweeted, tagging the Union Health Minister and the Drugs Controller General of India.

Show Full Article
Print Article
Next Story
More Stories
ADVERTISEMENT
ADVERTISEMENTS